Phaseline

Companies › Verrica Pharmaceuticals

Verrica Pharmaceuticals: clinical trials, targets and expected readouts

3 active drug programs in 3 registered trials: 3 Phase 3; Infectious disease; next expected readout Nov 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
VP-102
Cantharidin topical application
–Phase 3Common WartsNov 2026
VP-102 (US) / TO-208 (Japan)
Cantharidin-based topical treatment
–Phase 3Common WartsMay 2027
Cantharidin (YCANTH [VP-102/TO-208])
Blister-inducing topical agent with vesicant properties
–Phase 3Common Warts (Verruca Vulgaris)Nov 2027

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT07246590VP-102Phase 3Common WartsInfectious diseaseNov 2026
NCT07637734VP-102 (US) / TO-208 (Japan)Phase 3Common WartsInfectious diseaseMay 2027
NCT07457918Cantharidin (YCANTH [VP-102/TO-208])Phase 3Common Warts (Verruca Vulgaris)Infectious diseaseNov 2027

From the company's SEC filings

Cash of $11m on 2026-06-30; operating cash outflow about $37m a year; runway about 4 months at that burn, to Oct 2026; 0 of 3 coming phase 2-3 readouts fall inside that runway

Press releases filed as 8-K in the last year:

Complete response letters from FDA

Private offerings reported to the SEC (Form D)

Agreements filed with the SEC (item 1.01), last two years

Specialist investors

Held by 1 of the 39 life-science funds Phaseline follows through their 13F filings. Who holds what.

Targets

No annotated target.

Companies with the same targets

–

Companies built like this

Invivyd Traws Pharma Labo'Life 60 Degrees Pharmaceuticals Lakewood-Amedex

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.